Impleo Medical is a private company located in St. Paul, Minnesota. The Company has developed a proprietary bulking agent therapy for Gastric Esophageal Reflux Disease (GERD). Impleo’s management team has many years of experience in medical devices and is supported by an outstanding Board of Directors as well as recognized clinical leaders in the field of gastroenterology.
Impleo’s bulking agent is injected under sedation in the lower esophageal sphincter. It is designed to create a bulge and prevent or reduce the flow of gastric acid into the esophagus. Impleo has strong intellectual property which protects our invention.
The bulking agent is CE-marked in Europe for the treatment of GERD. It is currently under clinical investigation in the United States.